Salute e Benessere

Competitive Intelligence in Breast Cancer: Tracking the Evolving HR+ HER2-ve…

The HR+/HER2- breast cancer treatment market includes established drugs like KISQALI (Novartis), PIQRAY (Novartis), and IBRANCE (Pfizer). Despite these options, the market remains highly dynamic, with major players such as Merck, Arvinas, Olema Pharmaceuticals, Celcuity, Roche, AstraZeneca, Daiichi Sankyo, Eli Lilly, Sermonix Pharmaceuticals, Genentech, Veru Pharma, DualityBio, BioNTech, Evgen Pharma, Carrick Therapeutics, EQRx, G1 Therapeutics, and Immutep driving innovation. The…
PR Newswire
03/02/2025

Transparency Notifications from Shareholders

Transparency Notifications from ShareholdersGhent, Belgium – 3 February 2025 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications in relation to the entities listed below, notifying the number of voting rights attached to the shares mentioned next to their name in the table below. Reason for...
Nasdaq GlobeNewswire
03/02/2025

LabConnect Announces Formation of Strategic Advisory Board and Appointment of…

Scott EvangelistaMr. Evangelista brings over 30 years of pharmaceutical leadership experience to the board. He is currently the CEO of Cairn Therapeutics, Inc., where he directs the company's strategy, fundraising, and stakeholder management. Previously, Scott served as Executive Chairman at Cairn and has held prominent roles such as President and COO of Ironshore Pharmaceuticals, President of Integrated Health Services at IQVIA (formerly Quintiles), and Principal of the Life Sciences Commercial…
PR Newswire
03/02/2025

Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded…

Travel Health business demonstrated strong growth of 22%.Additional mpox vaccine orders during outbreak drove higher revenues for the Public Preparedness business and also secured a strong foundation for 2025.Financial guidance for 2025 in line with the Company's 2024-2027 ambitions.COPENHAGEN, Denmark, February 3, 2025– Bavarian Nordic A/S (OMX: BAVA) today announced preliminary, unaudited financial results for 2024 and provided its financial guidance for 2025.The preliminary...
Nasdaq GlobeNewswire
03/02/2025

Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision…

"Exacta AI signifies a paradigm shift in the multi-omic analysis of tumors and the approach to treatment decision making for complex cancer cases," asserts Dr Andy Gaya, Clinical Oncologist, Cromwell Hospital, London. "This next generation technology provides an unprecedented level of therapy analysis in treatment selection that is aimed at improving patient outcomes while reducing avoidable exposure to ineffective therapies." "Exacta AI signifies a paradigm shift in the…
PR Newswire
03/02/2025

Preclinical Imaging Market to Reach $3.02 Billion by 2030 | Rising Demand for…

Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-29U1060/Global_Preclinical_Imaging_Market Claim Your Free Report:https://reports.valuates.com/request/sample/QYRE-Auto-29U1060/Global_Preclinical_Imaging_Market Major Factors Driving the Growth of Preclinical Imaging Market: The Preclinical Imaging Market is poised for substantial growth, driven by the escalating demand for advanced imaging solutions in drug development and translational research...
PR Newswire
03/02/2025

Burn Care Market to Reach $4.32 Billion by 2031 - Exclusive Report by Meticulous…

Download FREE PDF Brochure Of Burn Care Market - https://www.meticulousresearch.com/download-sample-report/cp_id=6104 Download FREE PDF Brochure Of Burn Care Market - https://www.meticulousresearch.com/download-sample-report/cp_id=6104 The growth of the burn care market is driven by the rising incidence of burn injuries, government initiatives aimed at preventing burn injuries, increased awareness and accessibility to burn care products, and the growing availability of treatment...
PR Newswire
03/02/2025

Telehealth Market & Telemedicine Market to Hit USD 180.86 Billion by 2030 with…

Browse in-depth TOC on "Telehealth Market & Telemedicine Market" Browse in-depth TOC on "Telehealth Market & Telemedicine Market" 350 - Tables50 - Figures400 - Pages Government initiatives to improve access to healthcare also play a vital role, often providing funding and resources to strengthen telehealth infrastructure, especially in underserved regions. Collaboration between technology firms and healthcare delivery organizations is a very important determinant…
PR Newswire
03/02/2025

BioAro launches AI-Driven PanOmiQ with Ultrafast Whole Genome Sequencing…

Transforming Genomic Medicine with Unprecedented Speed, Accuracy, and Accessibility - PanOmiQ Sets a New Standard with Analysis Time from VCF Files Under 5 Minutes, and Less Than 2 hrs for FASTQ Files BioAro, a global leader in precision health and genomics, will unveil its groundbreaking AI-powered PanOmiQ platform at the prestigiousPrecision Medicine World Conference(PMWC) in Silicon Valley. This Whole Genome Sequencing (WGS) solution achieves unparalleled efficiency, reducing...
Nasdaq GlobeNewswire
03/02/2025

Moore Market analysis: Zero Candida potential market will reach over $2 Billion…

The analysis emphasis that up to 75% of women will have at least one vaginal yeast infection in their life, Moreover, recurrent VVC (Vulvovaginal Candidiasis) affects nearly 8% of women globally (for women above the ages of 15-60). According to the data, 100% of women with Recurrent VVC will purchase a combination of over-the-counter and prescription antifungal treatments, usually with the common use of oral agents. Compared to women with non-recurrent VCC, 55.2% will purchase prescription…
PR Newswire
03/02/2025

King Faisal Specialist Hospital & Research Centre Ranks 15th Globally

Maintaining its Leadership in the Middle East and North Africa RIYADH, Saudi Arabia, Feb.03, 2025(GLOBE NEWSWIRE) -- In an unprecedented achievement reflecting its excellence in specialized healthcare and medical research, King Faisal Specialist Hospital & Research Centre (KFSHRC) has been ranked 15th globally among the world's top 250 academic medical centres (AMCs) for 2025, cementing its position as the leading hospital in the Middle East and North Africa according to the...
Nasdaq GlobeNewswire
03/02/2025

uniQure Announces Completion of Enrollment in the First Cohort and Favorable…

~ Independent Data Monitoring Committee recommends proceeding with dosing of second cohort after planned safety assessment ~~ Company expects to initiate enrollment of second dose cohort in the first quarter of 2025 ~ LEXINGTON, Mass. and AMSTERDAM, Feb.03, 2025(GLOBE NEWSWIRE) --uniQureN.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the completion of enrollment in the first cohort of...
Nasdaq GlobeNewswire
03/02/2025

BioNTech Completes Acquisition of Biotheus

Acquisition to strengthen key pillar of BioNTech's oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the treatment of advanced cancersWith the closing of the transaction, BioNTech will expand its capabilities to develop, manufacture and commercialize novel BNT327 combinations and next-generation bispecific antibodiesBiotheus will become a new indirect Chinese subsidiary of BioNTech, adding a local research and development hub and an advanced...
Nasdaq GlobeNewswire
03/02/2025

GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF

Implementation of a Liquidity Contract with NATIXIS ODDO BHFVillepinte, 3 February 2025:Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, ends its liquidity contract ongoing since 9 March 2022 and announces having appointed NATIXIS and ODDO BHF to implement a liquidity contract, starting on 3 February 2025, for a period of one year tacitly renewable.This contract complies with the decision of the Autorité des marchés financiers...
Nasdaq GlobeNewswire
03/02/2025

AliveDx Expands Autoimmune Menu with IVDR-CE Marked MosaiQ AiPlex® CTDplus…

Systemic autoimmune Rheumatic Diseases such as Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus, Systemic Sclerosis (also known as Scleroderma), Sjögren's syndrome, idiopathic inflammatory Myopathies and mixed connective tissue diseases affect millions worldwide and are associated with autoantibody production. Systemic autoimmune Rheumatic Diseases such as Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus, Systemic Sclerosis (also known as Scleroderma), Sjögren's syndrome,...
PR Newswire
03/02/2025

Director/PDMR Shareholding

DXS INTERNATIONAL PLC(AQSE: DXSP)Notification of Director / PDMR DealingDXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 31 January, Mr Bob Sutcliffe, the Chairman, purchased 20,000 Ordinary Shares in the Company at a price of 3.5p per share.Following this transaction Mr Sutcliffe and his wife's...
Nasdaq GlobeNewswire
03/02/2025

EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio…

EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and EuropeParis, France (3 February 2025)– EssilorLuxottica announced today that it has received clearance from the Food and Drug Administration (FDA) for its OTC Nuance Audio Glasses. The Group has simultaneously achieved the CE marking under the Medical Devices Regulation in the EU, alongside the development of an ISO Quality Management System certification...
Nasdaq GlobeNewswire
03/02/2025

Press Release: Sanofi announces buy back of shares from L'Oréal

Sanofi announces buy back of shares from L'OréalParis, February 3, 2025.Sanofi today announces the acquisition of 2.3% of its shares from long-standing shareholder L'Oréal. This transaction is part of Sanofi's share buyback program announced on January 30, 2025. It is fully aligned with Sanofi's capital allocation policy and focus on sustainable value creation for shareholders.François RogerChief Financial Officer, Sanofi“L'Oréal has been a trusted shareholder and partner for...
Nasdaq GlobeNewswire
03/02/2025

Francisco Ballester to retire; Peter Stenico appointed President Region…

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules President Region International, Francisco Ballester, to retire as of March 1, 2025, after 34 years of servicePeter Stenico, currently Global Platform Head Biosimilars and Country President Sandoz Austria, concurrently appointed President Region International and a member of the Sandoz Executive CommitteeBasel, February 3, 2025 –Sandoz, the global leader in generic and biosimilar medicines, announced today that...
Nasdaq GlobeNewswire
03/02/2025

Fapon at Medlab Middle East 2025: Advancing Local Diagnostic Industry through…

Fapon's CLIA and biochemistry product lines exemplify its expertise in One-stop IVD solutions. Its CLIA One-stop solution includes the Shine i-series open-system CLIA analyzers for low- to ultra-high-throughput testing, alongside over 80 reagent services for assays such as vitamin D, NT-proBNP，hs-cTnI and PCT, and core IVD raw materials. Fapon is able to provide one-stop CLIA products and services from development, evaluation/registration, QMS construction to after-sales. In addition, Fapon's…
PR Newswire
03/02/2025

Wingderm® at IMCAS: Showcasing the Latest Innovations in Laser Hair Removal and…

Lasermach Duo: A Milestone in Laser Hair Removal Innovation Lasermach Duo: A Milestone in Laser Hair Removal Innovation Lasermach Duo, the newest generation of laser hair removal solution, offers effective treatments for all hair types and skin tones with three wavelengths. Dual handpieces with an innovative connection structure for easy installation, combined with an enhanced cooling system, enable practitioners to achieve excellent clinical results while providing beauty seekers with...
PR Newswire
02/02/2025

From Nuremberg, out into the world: energy-charged Spielwarenmesse generates…

The barometer of exhibitors' opinion was also on the rise in terms of service and activities. "The continuous marked improvement in content at the Spielwarenmesse was clearly appreciated," confirms Christian Ulrich, Board Spokesperson at Spielwarenmesse eG. The addition of Hall 3C, accommodating Baby & Infant Articles and Lifestyle Products, made efficient circuits around the fair easier and created synergies. "We love the new hall and the stand we have there – it was a real…
PR Newswire
01/02/2025

United Imaging Unveils Groundbreaking Innovations and Strengthens Strategic…

These collaborations are a testament to United Imaging's role as a driving force in transforming healthcare, and they underscore the company's mission to deliver accessible, high-quality healthcare globally. These collaborations are a testament to United Imaging's role as a driving force in transforming healthcare, and they underscore the company's mission to deliver accessible, high-quality healthcare globally. Dr. Jusong Xia, President of International Business at United Imaging...
PR Newswire
01/02/2025

Evaxion announces closing of $10.8 million public offering

/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing of a public offering of an aggregate of 3,997,361 of its American Depositary Shares (“ADSs”) and warrants to purchase up to 50% of the ADSs offered at a combined public offering price of $2.71 per ADS with one accompanying warrant for each two ADSs.MSD Global Health Innovation Fund, a corporate venture capital arm of Merck & Co., Inc...
Nasdaq GlobeNewswire
31/01/2025
Altri  Comunicati